Discovery of compounds inhibiting SARS-COV-2 multi-targets

References

• Adedeji, A. O., & Lazarus, H. (2016). Biochemical characterization of Middle East respiratory syndrome coronavirus helicase. mSphere, 1(5), 1-14. https://doi.org/10.1128/mSphere.00235-16
   Google Scholar
• Adhikari, S. P., Meng, S., Wu, Y.-J., Mao, Y.-P., Ye, R.-X., Wang, Q.-Z., Sun, C., Sylvia, S., Rozelle, S., Raat, H., & Zhou, H. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infectious Diseases of Poverty, 9(1), 12. https://doi.org/10.1186/s40249-020-00646-x
   PubMedGoogle Scholar
• Ahn, D.-G., Choi, J.-K., Taylor, D. R., & Oh, J.-W. (2012). Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Archives of Virology, 157(11), 2095–2104. https://doi.org/10.1007/s00705-012-1404-x
   PubMed Web of Science ®Google Scholar
• Al-Sehemi, A. G., Pannipara, M., Parulekar, R. S., Patil, O., Choudhari, P. B., Bhatia, M., Zubaidha, P., & Tamboli, Y. (2020). Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: In silico analysis. Journal of Biomolecular Structure and Dynamics., 39, 1–15.
   Google Scholar
• Angelini, M. M., Akhlaghpour, M., Neuman, B. W., & Buchmeier, M. J. (2013). Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. MBio, 4(4), 1-10. https://doi.org/10.1128/mBio.00524-13
   PubMed Web of Science ®Google Scholar
• AstraZeneca. (2020). AZD1222 vaccine met primary efficacy endpoint in preventing COVID‐19.
   Google Scholar
• Beachboard, D. C., Anderson-Daniels, J. M., & Denison, M. R. (2015). Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. Journal of Virology, 89(4), 2080–2089. https://doi.org/10.1128/JVI.02776-14
   PubMedGoogle Scholar
• Bhardwaj, K., Sun, J., Holzenburg, A., Guarino, L. A., & Kao, C. C. (2006). RNA recognition and cleavage by the SARS coronavirus endoribonuclease. Journal of Molecular Biology, 361(2), 243–256. https://doi.org/10.1016/j.jmb.2006.06.021
   PubMed Web of Science ®Google Scholar
• Bouvet, M., Imbert, I., Subissi, L., Gluais, L., Canard, B., & Decroly, E. (2012). RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proceedings of the National Academy of Sciences of the United States of America, 109(24), 9372–9377. https://doi.org/10.1073/pnas.1201130109
   PubMed Web of Science ®Google Scholar
• Bouvet, M., Lugari, A., Posthuma, C. C., Zevenhoven, J. C., Bernard, S., Betzi, S., Imbert, I., Canard, B., Guillemot, J.-C., Lécine, P., Pfefferle, S., Drosten, C., Snijder, E. J., Decroly, E., & Morelli, X. (2014). Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. The Journal of Biological Chemistry, 289(37), 25783–25796. https://doi.org/10.1074/jbc.M114.577353
   PubMed Web of Science ®Google Scholar
• Brasil, S., Pascoal, C., Francisco, R., dos Reis Ferreira, V., A Videira, P., & Valadão, G. (2019). Artificial intelligence (AI) in rare diseases: Is the future brighter? Genes, 10(12), 978. https://doi.org/10.3390/genes10120978
   PubMedGoogle Scholar
• Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178, 104787. https://doi.org/10.1016/j.antiviral.2020.104787
   PubMed Web of Science ®Google Scholar
• Caly, L., Wagstaff, K. M., & Jans, D. A. (2012). Nuclear trafficking of proteins from RNA viruses: Potential target for antivirals? Antiviral Research, 95(3), 202–206. https://doi.org/10.1016/j.antiviral.2012.06.008
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., & Wei, M. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382, 1-13.
   Google Scholar
• Chan, K. H., Poon, L. L., Cheng, V., Guan, Y., Hung, I., Kong, J., Yam, L. Y., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M. (2004). Detection of SARS coronavirus in patients with suspected SARS. Emerging Infectious Diseases, 10(2), 294–299. https://doi.org/10.3201/eid1002.030610
   PubMedGoogle Scholar
• Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., Tsoi, H.-W., Lo, S. K.-F., Chan, K.-H., Poon, V. K.-M., Chan, W.-M., Ip, J. D., Cai, J.-P., Cheng, V. C.-C., Chen, H., Hui, C. K.-M., & Yuen, K.-Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet, 395(10223), 514–523. https://doi.org/10.1016/S0140-6736(20)30154-9
   PubMed Web of Science ®Google Scholar
• Chatterjee, B., & Thakur, S. S. (2020). ACE2 as a potential therapeutic target for pandemic COVID-19. RSC Advances, 10(65), 39808–39813. https://doi.org/10.1039/D0RA08228G
   PubMed Web of Science ®Google Scholar
• Chen, Y., Cai, H., Pan, J., Xiang, N., Tien, P., Ahola, T., & Guo, D. (2009). Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proceedings of the National Academy of Sciences of the United States of America, 106(9), 3484–3489. https://doi.org/10.1073/pnas.0808790106
   PubMed Web of Science ®Google Scholar
• Cheng, P. K., Wong, D. A., Tong, L. K., Ip, S.-M., Lo, A. C., Lau, C.-S., Yeung, E. Y., & Lim, W. W. (2004). Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. The Lancet, 363(9422), 1699–1700. https://doi.org/10.1016/S0140-6736(04)16255-7
   PubMed Web of Science ®Google Scholar
• Chen, C., Huang, J., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., Luo, Y., & Zhang, J. (2020). Favipiravir versus arbidol for COVID-19: A randomized clinical trial. MedRxiv, 1-29.
   Google Scholar
• Chen, Y., Su, C., Ke, M., Jin, X., Xu, L., Zhang, Z., Wu, A., Sun, Y., Yang, Z., Tien, P., Ahola, T., Liang, Y., Liu, X., & Guo, D. (2011). Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2′-O-methylation by nsp16/nsp10 protein complex. PLoS Pathogens, 7(10), e1002294. https://doi.org/10.1371/journal.ppat.1002294
   PubMed Web of Science ®Google Scholar
• Corman, V. M., Albarrak, A. M., Omrani, A. S., Albarrak, M. M., Farah, M. E., Almasri, M., Muth, D., Sieberg, A., Meyer, B., Assiri, A. M., Binger, T., Steinhagen, K., Lattwein, E., Al-Tawfiq, J., Müller, M. A., Drosten, C., & Memish, Z. A. (2016). Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 62(4), 477–483.
   PubMed Web of Science ®Google Scholar
• Cottam, E. M., Whelband, M. C., & Wileman, T. (2014). Coronavirus NSP6 restricts autophagosome expansion. Autophagy, 10(8), 1426–1441. https://doi.org/10.4161/auto.29309
   PubMed Web of Science ®Google Scholar
• De Clercq, E. (2004). Antivirals and antiviral strategies. Nature Reviews Microbiology, 2(9), 704–720. https://doi.org/10.1038/nrmicro975
   PubMed Web of Science ®Google Scholar
• De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews. Microbiology, 14(8), 523–534. https://doi.org/10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Decroly, E., Debarnot, C., Ferron, F., Bouvet, M., Coutard, B., Imbert, I., Gluais, L., Papageorgiou, N., Sharff, A., Bricogne, G., Ortiz-Lombardia, M., Lescar, J., & Canard, B. (2011). Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex. PLoS Pathogens, 7(5), e1002059. https://doi.org/10.1371/journal.ppat.1002059
   PubMed Web of Science ®Google Scholar
• Deng, X., Hackbart, M., Mettelman, R. C., O'Brien, A., Mielech, A. M., Yi, G., Kao, C. C., & Baker, S. C. (2017). Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proceedings of the National Academy of Sciences of the United States of America, 114(21), E4251–E4260. https://doi.org/10.1073/pnas.1618310114
   PubMed Web of Science ®Google Scholar
• Eckerle, L. D., Becker, M. M., Halpin, R. A., Li, K., Venter, E., Lu, X., Scherbakova, S., Graham, R. L., Baric, R. S., Stockwell, T. B., Spiro, D. J., & Denison, M. R. (2010). Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathogens, 6(5), e1000896. https://doi.org/10.1371/journal.ppat.1000896
   PubMed Web of Science ®Google Scholar
• Egloff, M.-P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E. J., Gorbalenya, A. E., Cambillau, C., & Canard, B. (2004). The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proceedings of the National Academy of Sciences of the United States of America, 101(11), 3792–3796. https://doi.org/10.1073/pnas.0307877101
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477. https://doi.org/10.1016/j.lfs.2020.117477
   PubMed Web of Science ®Google Scholar
• Fang, S. G., Shen, H., Wang, J., Tay, F. P., & Liu, D. X. (2008). Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of Coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells. Virology, 379(2), 175–180. https://doi.org/10.1016/j.virol.2008.06.038
   PubMed Web of Science ®Google Scholar
• Furuta, Y., Komeno, T., & Nakamura, T. (2017). Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 93(7), 449–463. https://doi.org/10.2183/pjab.93.027
   PubMed Web of Science ®Google Scholar
• Gadlage, M. J., Graham, R. L., & Denison, M. R. (2008). Murine coronaviruses encoding nsp2 at different genomic loci have altered replication, protein expression, and localization. Journal of Virology, 82(23), 11964–11969. https://doi.org/10.1128/JVI.01126-07
   PubMedGoogle Scholar
• Gadlage, M. J., Sparks, J. S., Beachboard, D. C., Cox, R. G., Doyle, J. D., Stobart, C. C., & Denison, M. R. (2010). Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. Journal of Virology, 84(1), 280–290. https://doi.org/10.1128/JVI.01772-09
   PubMedGoogle Scholar
• Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., & Martinez, A. (2020). COVID-19: Drug targets and potential treatments. Journal of Medicinal Chemistry, 63(21), 12359–12386. https://doi.org/10.1021/acs.jmedchem.0c00606
   PubMed Web of Science ®Google Scholar
• Graham, R. L., Sims, A. C., Brockway, S. M., Baric, R. S., & Denison, M. R. (2005). The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication. Journal of Virology, 79(21), 13399–13411. https://doi.org/10.1128/JVI.79.21.13399-13411.2005
   PubMedGoogle Scholar
• Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., Du, B., Li, L.-J., Zeng, G., Yuen, K.-Y., Chen, R.-C., Tang, C.-L., Wang, T., Chen, P.-Y., Xiang, J., … Zhong, N.-S, China Medical Treatment Expert Group for Covid-19. (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Guebre-Xabier, M., Patel, N., Tian, J.-H., Zhou, B., Maciejewski, S., Lam, K., Portnoff, A. D., Massare, M. J., Frieman, M. B., Piedra, P. A., Ellingsworth, L., Glenn, G., & Smith, G. (2020). NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine, 38(50), 7892–7896. https://doi.org/10.1016/j.vaccine.2020.10.064
   PubMed Web of Science ®Google Scholar
• Hamza, M., Ali, A., Khan, S., Ahmed, S., Attique, Z., Ur Rehman, S., Khan, A., Ali, H., Rizwan, M., & Munir, A. (2020). nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. Journal of Biomolecular Structure and Dynamics, 39, 1–11.
   Google Scholar
• Hao, W., Wojdyla, J. A., Zhao, R., Han, R., Das, R., Zlatev, I., Manoharan, M., Wang, M., & Cui, S. (2017). Crystal structure of Middle East respiratory syndrome coronavirus helicase. PLoS Pathogens, 13(6), e1006474. https://doi.org/10.1371/journal.ppat.1006474
   PubMed Web of Science ®Google Scholar
• Hindson, J. (2020). COVID-19: Faecal-oral transmission? Nature Reviews Gastroenterology & Hepatology, 17(5), 259–259. https://doi.org/10.1038/s41575-020-0295-7
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280. https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Huang, C., Lokugamage, K. G., Rozovics, J. M., Narayanan, K., Semler, B. L., & Makino, S. (2011). SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: Viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathogens, 7(12), e1002433. https://doi.org/10.1371/journal.ppat.1002433
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Hung, I. F. N., Cheng, V. C. C., Wu, A. K. L., Tang, B. S. F., Chan, K. H., Chu, C. M., Wong, M. M. L., Hui, W. T., Poon, L. L. M., Tse, D. M. W., Chan, K. S., Woo, P. C. Y., Lau, S. K. P., Peiris, J. S. M., & Yuen, K. Y. (2004). Viral loads in clinical specimens and SARS manifestations. Emerging Infectious Diseases, 10(9), 1550–1557. https://doi.org/10.3201/eid1009.040058
   PubMed Web of Science ®Google Scholar
• Hussain, S., Pan, J., Chen, Y., Yang, Y., Xu, J., Peng, Y., Wu, Y., Li, Z., Zhu, Y., Tien, P., & Guo, D. (2005). Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. Journal of Virology, 79(9), 5288–5295. https://doi.org/10.1128/JVI.79.9.5288-5295.2005
   PubMed Web of Science ®Google Scholar
• Jackson, N. A., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020). The promise of mRNA vaccines: A biotech and industrial perspective. npj Vaccines, 5(1), 1–6. https://doi.org/10.1038/s41541-020-0159-8
   PubMed Web of Science ®Google Scholar
• Jia, Z., Yan, L., Ren, Z., Wu, L., Wang, J., Guo, J., Zheng, L., Ming, Z., Zhang, L., Lou, Z., & Rao, Z. (2019). Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Research, 47(12), 6538–6550. https://doi.org/10.1093/nar/gkz409
   PubMed Web of Science ®Google Scholar
• Kadam, R. U., & Wilson, I. A. (2017). Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proceedings of the National Academy of Sciences of the United States of America, 114(2), 206–214. https://doi.org/10.1073/pnas.1617020114
   PubMed Web of Science ®Google Scholar
• Kirchdoerfer, R. N., & Ward, A. B. (2019). Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications, 10(1), 1–9. https://doi.org/10.1038/s41467-019-10280-3
   PubMedGoogle Scholar
• Koren, G., King, S., Knowles, S., & Phillips, E. (2003). Ribavirin in the treatment of SARS: A new trick for an old drug? CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne, 168(10), 1289–1292.
   PubMed Web of Science ®Google Scholar
• Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020). The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine, 172(9), 577–582. https://doi.org/10.7326/M20-0504
   PubMed Web of Science ®Google Scholar
• Lei, J., Kusov, Y., & Hilgenfeld, R. (2018). Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Research, 149, 58–74. https://doi.org/10.1016/j.antiviral.2017.11.001
   PubMed Web of Science ®Google Scholar
• Li, H., Zhou, Y., Zhang, M., Wang, H., Zhao, Q., & Liu, J. (2020). Updated approaches against SARS-CoV-2. Antimicrobial Agents and Chemotherapy., 64, 1-7.
   Google Scholar
• Liu, W., Tang, F., Fontanet, A., Zhan, L., Zhao, Q.-M., Zhang, P.-H., Wu, X.-M., Zuo, S.-Q., Baril, L., Vabret, A., Xin, Z.-T., Shao, Y.-M., Yang, H., & Cao, W.-C. (2004). Long-term SARS coronavirus excretion from patient cohort, China. Emerging Infectious Diseases, 10(10), 1841–1843. https://doi.org/10.3201/eid1010.040297
   PubMedGoogle Scholar
• Ma, Y., Wu, L., Shaw, N., Gao, Y., Wang, J., Sun, Y., Lou, Z., Yan, L., Zhang, R., & Rao, Z. (2015). Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proceedings of the National Academy of Sciences of the United States of America, 112(30), 9436–9441. https://doi.org/10.1073/pnas.1508686112
   PubMed Web of Science ®Google Scholar
• Makhoba, X. H., Viegas, C., Jr, Mosa, R. A., Viegas, F. P., & Pooe, O. J. (2020). Potential impact of the multi-target drug approach in the treatment of some complex diseases. Drug Design, Development and Therapy, 14, 3235–3249. https://doi.org/10.2147/DDDT.S257494
   PubMed Web of Science ®Google Scholar
• Memish, Z. A., Assiri, A. M., & Al-Tawfiq, J. A. (2014). Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: An observational analysis with infection control implications. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 29, 307–308. https://doi.org/10.1016/j.ijid.2014.10.002
   PubMed Web of Science ®Google Scholar
• Minskaia, E., Hertzig, T., Gorbalenya, A. E., Campanacci, V., Cambillau, C., Canard, B., & Ziebuhr, J. (2006). Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis. Proceedings of the National Academy of Sciences of the United States of America, 103(13), 5108–5113. https://doi.org/10.1073/pnas.0508200103
   PubMed Web of Science ®Google Scholar
• Moderna, Ms. (2020). COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 COVE study. Moderna, 16
   Google Scholar
• Monteiro, N. R., Ribeiro, B., & Arrais, J. (2020). Drug-target interaction prediction: End-to-end deep learning approach. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 18, 2364-2374.
   Google Scholar
• Mueller, S., Stauft, C. B., Kalkeri, R., Koidei, F., Kushnir, A., Tasker, S., & Coleman, J. R. (2020). A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates. Vaccine, 38(14), 2943–2948. https://doi.org/10.1016/j.vaccine.2020.02.056
   PubMed Web of Science ®Google Scholar
• Mulangu, S., Dodd, L. E., Davey, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., Ibanda, A., Ali, R., Coulibaly, S., Levine, A. C., Grais, R., Diaz, J., Lane, H. C., Muyembe-Tamfum, J.-J., Sivahera, B., Camara, M., … Nordwall, J., PALM Consortium Study Team. (2019). A randomized, controlled trial of Ebola virus disease therapeutics. The New England Journal of Medicine, 381(24), 2293–2303. https://doi.org/10.1056/NEJMoa1910993
   PubMed Web of Science ®Google Scholar
• Murray, C. J., & Piot, P. (2021). The potential future of the COVID-19 pandemic: Will SARS-CoV-2 become a recurrent seasonal infection? Jama, 325(13), 1249–1250. https://doi.org/10.1001/jama.2021.2828
   PubMed Web of Science ®Google Scholar
• Murugan, N. A., Kumar, S., Jeyakanthan, J., & Srivastava, V. (2020). Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach. Scientific Reports., 10, 1–16.
   PubMed Web of Science ®Google Scholar
• Nascimento, A. C., Prudêncio, R. B., & Costa, I. G. (2019). A drug-target network-based supervised machine learning repurposing method allowing the use of multiple heterogeneous information sources, In Computational Methods for Drug Repurposing (pp. 281–289). Springer.
   Google Scholar
• Nath, A., Kumari, P., & Chaube, R. (2018). Prediction of human drug targets and their interactions using machine learning methods: Current and future perspectives. Computational Drug Discovery and Design, 21–30.
   Google Scholar
• Pasquereau, S., Nehme, Z., Haidar Ahmad, S., Daouad, F., Van Assche, J., Wallet, C., Schwartz, C., Rohr, O., Morot-Bizot, S., & Herbein, G. (2021). Resveratrol inhibits HCoV-229E and SARS-CoV-2 coronavirus replication in vitro. Viruses, 13(2), 354. https://doi.org/10.3390/v13020354
   PubMedGoogle Scholar
• Peiris, J. S. M., Chu, C. M., Cheng, V. C. C., Chan, K. S., Hung, I. F. N., Poon, L. L. M., Law, K. I., Tang, B. S. F., Hon, T. Y. W., Chan, C. S., Chan, K. H., Ng, J. S. C., Zheng, B. J., Ng, W. L., Lai, R. W. M., Guan, Y., & Yuen, K. Y. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. The Lancet, 361(9371), 1767–1772. https://doi.org/10.1016/S0140-6736(03)13412-5
   PubMed Web of Science ®Google Scholar
• Poland, G. A., Ovsyannikova, I. G., Crooke, S. N., & Kennedy, R. B. (2020). SARS-CoV-2 vaccine development: Current status. Mayo Clinic Proceedings, 95(10), 2172–2188. https://doi.org/10.1016/j.mayocp.2020.07.021
   PubMedGoogle Scholar
• Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., Paniz-Mondolfi, A., Lagos-Grisales, G. J., Ramírez-Vallejo, E., Suárez, J. A., Zambrano, L. I., Villamil-Gómez, W. E., Balbin-Ramon, G. J., Rabaan, A. A., Harapan, H., … Sah, R. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease, 34, 101623. https://doi.org/10.1016/j.tmaid.2020.101623
   PubMed Web of Science ®Google Scholar
• Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., Seilmaier, M., Drosten, C., Vollmar, P., Zwirglmaier, K., Zange, S., Wölfel, R., & Hoelscher, M. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. The New England Journal of Medicine, 382(10), 970–971. https://doi.org/10.1056/NEJMc2001468
   PubMed Web of Science ®Google Scholar
• Runfeng, L., Yunlong, H., Jicheng, H., Weiqi, P., Qinhai, M., Yongxia, S., Chufang, L., Jin, Z., Zhenhua, J., Haiming, J., Kui, Z., Shuxiang, H., Jun, D., Xiaobo, L., Xiaotao, H., Lin, W., Nanshan, Z., & Zifeng, Y. (2020). Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacological Research, 156, 104761. https://doi.org/10.1016/j.phrs.2020.104761
   PubMed Web of Science ®Google Scholar
• Saberian, N., Peyvandipour, A., Donato, M., Ansari, S., & Draghici, S. (2019). A new computational drug repurposing method using established disease-drug pair knowledge. Bioinformatics (Oxford, England), 35(19), 3672–3678. https://doi.org/10.1093/bioinformatics/btz156
   PubMedGoogle Scholar
• Sapkal, G. N., Yadav, P. D., Ella, R., Deshpande, G. R., Sahay, R. R., Gupta, N., Mohan, V. K., Abraham, P., Panda, S., & Bhargava, B. (2021). Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1. 7 variant of SARS-CoV-2. Journal of Travel Medicine, 28, 1–3.
   Google Scholar
• Sarzi-Puttini, P., Giorgi, V., Sirotti, S., Marotto, D., Ardizzone, S., Rizzardini, G., Antinori, S., & Galli, M. (2020). COVID-19, cytokines and immunosuppression: What can we learn from severe acute respiratory syndrome? Clinical and Experimental Rheumatology, 38(2), 337–342.
   PubMed Web of Science ®Google Scholar
• Sasidharan, S., Selvaraj, C., Singh, S. K., Dubey, V. K., Kumar, S., Fialho, A. M., & Saudagar, P. (2020). Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: Insights from molecular docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 39, 1–16.
   Google Scholar
• Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003). Effects of chloroquine on viral infections: An old drug against today's diseases. The Lancet Infectious Diseases, 3(11), 722–727. https://doi.org/10.1016/S1473-3099(03)00806-5
   PubMed Web of Science ®Google Scholar
• Saxena, A. (2020). Drug targets for COVID-19 therapeutics: Ongoing global efforts. Journal of Biosciences, 45, 1–24.
   PubMed Web of Science ®Google Scholar
• Serrano, P., Johnson, M. A., Chatterjee, A., Neuman, B. W., Joseph, J. S., Buchmeier, M. J., Kuhn, P., & Wüthrich, K. (2009). Nuclear magnetic resonance structure of the nucleic acid-binding domain of severe acute respiratory syndrome coronavirus nonstructural protein 3. Journal of Virology, 83(24), 12998–13008. https://doi.org/10.1128/JVI.01253-09
   PubMedGoogle Scholar
• Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M. F., Hussain, A., Rehman, M., Islam, A., & Hassan, M. (2020). Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy. Bioscience Reports, 40, 1-8.
   PubMed Web of Science ®Google Scholar
• Shang, J., Ye, G., Shi, K., Wan, Y., Aihara, H., & Li, F. (2020). Structure of 2019-nCoV chimeric receptor-binding domain complexed with its receptor human ACE2. Worldw. Protein Data Bank.
   Google Scholar
• Shi, P., Su, Y., Li, R., Liang, Z., Dong, S., & Huang, J. (2019). PEDV nsp16 negatively regulates innate immunity to promote viral proliferation. Virus Research, 265, 57–66. https://doi.org/10.1016/j.virusres.2019.03.005
   PubMed Web of Science ®Google Scholar
• Sputnik, V. (2020). Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose. Press Release, 24 November 2020. sputnikvaccine. com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d.
   Google Scholar
• Spychalski, P., Błażyńska-Spychalska, A., & Kobiela, J. (2020). Estimating case fatality rates of COVID-19. The Lancet. Infectious Diseases.
   Google Scholar
• Stobart, C. C., Sexton, N. R., Munjal, H., Lu, X., Molland, K. L., Tomar, S., Mesecar, A. D., & Denison, M. R. (2013). Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity. Journal of Virology, 87(23), 12611–12618. https://doi.org/10.1128/JVI.02050-13
   PubMed Web of Science ®Google Scholar
• Surveillances. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly, 2(8), 113–122. https://doi.org/10.46234/ccdcw2020.032
   PubMedGoogle Scholar
• Talevi, A. (2015). Multi-target pharmacology: Possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective. Frontiers in Pharmacology, 6, 205. https://doi.org/10.3389/fphar.2015.00205
   PubMed Web of Science ®Google Scholar
• Tanaka, T., Kamitani, W., DeDiego, M. L., Enjuanes, L., & Matsuura, Y. (2012). Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. Journal of Virology, 86(20), 11128–11137. https://doi.org/10.1128/JVI.01700-12
   PubMed Web of Science ®Google Scholar
• Te Velthuis, A. J., Arnold, J. J., Cameron, C. E., van den Worm, S. H., & Snijder, E. J. (2010). The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Research, 38(1), 203–214. https://doi.org/10.1093/nar/gkp904
   PubMed Web of Science ®Google Scholar
• Te Velthuis, A. J., Van Den Worm, S. H., & Snijder, E. J. (2012). The SARS-coronavirus nsp7 + nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Research, 40(4), 1737–1747. https://doi.org/10.1093/nar/gkr893
   PubMed Web of Science ®Google Scholar
• Tebas, P., Yang, S., Boyer, J. D., Reuschel, E. L., Patel, A., Christensen-Quick, A., Andrade, V. M., Morrow, M. P., Kraynyak, K., Agnes, J., Purwar, M., Sylvester, A., Pawlicki, J., Gillespie, E., Maricic, I., Zaidi, F. I., Kim, K. Y., Dia, Y., Frase, D., … Humeau, L. M. (2021). Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine, 31, 100689. https://doi.org/10.1016/j.eclinm.2020.100689
   PubMedGoogle Scholar
• Ton, A. T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS‐CoV‐2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39(8), 2000028. https://doi.org/10.1002/minf.202000028
   PubMed Web of Science ®Google Scholar
• Tong, T. R. (2009). Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections. Infectious Disorders Drug Targets, 9(2), 223–245. https://doi.org/10.2174/187152609787847659
   PubMedGoogle Scholar
• Ura, T., Okuda, K., & Shimada, M. (2014). Developments in viral vector-based vaccines. Vaccines, 2(3), 624–641. https://doi.org/10.3390/vaccines2030624
   PubMedGoogle Scholar
• Vela, J. M. (2020). Repurposing sigma-1 receptor ligands for COVID-19 therapy? Frontiers in Pharmacology, 11, 582310. https://doi.org/10.3389/fphar.2020.582310
   PubMedGoogle Scholar
• Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health: TM & IH, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
   PubMed Web of Science ®Google Scholar
• Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2(1), 69. https://doi.org/10.1186/1743-422X-2-69
   PubMed Web of Science ®Google Scholar
• Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., & Jans, D. A. (2012). Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. The Biochemical Journal, 443(3), 851–856. https://doi.org/10.1042/BJ20120150
   PubMed Web of Science ®Google Scholar
• Walsh, E. E., Frenck, R. W., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fontes-Garfias, C., Shi, P.-Y., Türeci, Ö., Tompkins, K. R., … Gruber, W. C. (2020). Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. The New England Journal of Medicine, 383(25), 2439–2450. https://doi.org/10.1056/NEJMoa2027906
   PubMed Web of Science ®Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020b). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020a). Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020c). Detection of SARS-CoV-2 in different types of clinical specimens. Jama, 323(18), 1843–1844. https://doi.org/10.1001/jama.2020.3786
   PubMed Web of Science ®Google Scholar
• Ward, B. J., Gobeil, P., Seguin, A., Atkins, J., Boulay, I., Charbonneau, P.-Y., Couture, M., D'Aoust, M.-A., Dhaliwall, J., & Finkle, C. (2020). Phase 1 trial of a candidate recombinant virus-like particle vaccine for Covid-19 disease produced in plants. medRxiv, 1–58.
   Google Scholar
• Wu, D., & Yang, X. O. (2020). TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. Journal of Microbiology, Immunology and Infection, 53, 368-370.
   Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020a). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Wu, S., Zhong, G., Zhang, J., Shuai, L., Zhang, Z., Wen, Z., Wang, B., Zhao, Z., Song, X., Chen, Y., Liu, R., Fu, L., Zhang, J., Guo, Q., Wang, C., Yang, Y., Fang, T., Lv, P., Wang, J., … Chen, W. (2020b). A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature Communications, 11(1), 7. https://doi.org/10.1038/s41467-020-17972-1
   PubMedGoogle Scholar
• Xia, S., Zhang, Y., Wang, Y., Wang, H., Yang, Y., Gao, G. F., Tan, W., Wu, G., Xu, M., Lou, Z., Huang, W., Xu, W., Huang, B., Wang, H., Wang, W., Zhang, W., Li, N., Xie, Z., Ding, L., … Yang, X. (2021). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: A randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases, 21(1), 39–51. https://doi.org/10.1016/S1473-3099(20)30831-8
   PubMed Web of Science ®Google Scholar
• Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., Zhang, H., Liu, H., Xia, H., Tang, J., Zhang, K., & Gong, S. (2020). Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature Medicine, 26(4), 502–505. https://doi.org/10.1038/s41591-020-0817-4
   PubMed Web of Science ®Google Scholar
• Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., Lau, S. K., Anderson, D. E., Chan, K. S., Tan, T. Y., Ng, T. Y., Cui, L., Said, Z., Kurupatham, L., Chen, M. I.-C., … Lye, D. C., Singapore 2019 Novel Coronavirus Outbreak Research Team. (2020). Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA, 323(15), 1488–1494. https://doi.org/10.1001/jama.2020.3204
   PubMed Web of Science ®Google Scholar
• Yu, P., Zhu, J., Zhang, Z., & Han, Y. (2020). A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. The Journal of Infectious Diseases, 221(11), 1757–1761. https://doi.org/10.1093/infdis/jiaa077
   PubMed Web of Science ®Google Scholar
• Zeng, Z., Deng, F., Shi, K., Ye, G., Wang, G., Fang, L., Xiao, S., Fu, Z., & Peng, G. (2018). Dimerization of coronavirus nsp9 with diverse modes enhances its nucleic acid binding affinity. Journal of Virology, 92, 1-15.
   Google Scholar
• Zeng, X., Zhu, S., Hou, Y., Zhang, P., Li, L., Li, J., Huang, L. F., Lewis, S. J., Nussinov, R., & Cheng, F. (2020). Network-based prediction of drug-target interactions using an arbitrary-order proximity embedded deep forest . Bioinformatics (Oxford, England), 36(9), 2805–2812. https://doi.org/10.1093/bioinformatics/btaa010
   PubMedGoogle Scholar
• Zhai, Y., Sun, F., Li, X., Pang, H., Xu, X., Bartlam, M., & Rao, Z. (2005). Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nature Structural & Molecular Biology, 12(11), 980–986. https://doi.org/10.1038/nsmb999
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Chen, C., Zhu, S., Shu, C., Wang, D., Song, J., Song, Y., Zhen, W., Feng, Z., Wu, G., Xu, J., & Xu, W. (2020b). Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19). China CDC Weekly, 2(8), 123–124. https://doi.org/10.46234/ccdcw2020.033
   PubMedGoogle Scholar
• Zhang, W., Du, R.-H., Li, B., Zheng, X.-S., Yang, X.-L., Hu, B., Wang, Y.-Y., Xiao, G.-F., Yan, B., Shi, Z.-L., & Zhou, P. (2020a). Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerging Microbes & Infections, 9(1), 386–389. https://doi.org/10.1080/22221751.2020.1729071
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020d). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Li, J., Ou, Y., Yang, G., Deng, K., Wang, Q., Wang, Z., Wang, W., Zhang, Q., Wang, H., Sun, W., Sun, P., & Yang, S. (2020c). Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduction and Targeted Therapy, 5(1), 25. https://doi.org/10.1038/s41392-020-00213-8
   PubMed Web of Science ®Google Scholar
• Zhang, L., Li, L., Yan, L., Ming, Z., Jia, Z., Lou, Z., & Rao, Z. (2018). Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East respiratory syndrome coronavirus. Journal of Virology, 92, 1-16.
   Google Scholar
• Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020e). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586–590. https://doi.org/10.1007/s00134-020-05985-9
   PubMed Web of Science ®Google Scholar
• Zhao, K., & So, H.-C. (2019). Drug repositioning for schizophrenia and depression/anxiety disorders: A machine learning approach leveraging expression data. IEEE Journal of Biomedical and Health Informatics, 23(3), 1304–1315. https://doi.org/10.1109/JBHI.2018.2856535
   PubMedGoogle Scholar
• Zhuang, G., Shen, M., Zeng, L., Mi, B., Chen, F., Liu, W., Pei, L., Qi, X., & Li, C. (2020). WITHDRAWN: Potential false-positive rate among the'asymptomatic infected individuals' in close contacts of COVID-19 patients. Zhonghua Liu Xing Bing Xue za Zhi = Zhonghua Liuxingbingxue Zazhi, 41(4), 485–488.
   PubMedGoogle Scholar
• Zhu, X., Fang, L., Wang, D., Yang, Y., Chen, J., Ye, X., Foda, M. F., & Xiao, S. (2017a). Porcine deltacoronavirus nsp5 inhibits interferon-β production through the cleavage of NEMO. Virology, 502, 33–38. https://doi.org/10.1016/j.virol.2016.12.005
   PubMedGoogle Scholar
• Zhu, X., Wang, D., Zhou, J., Pan, T., Chen, J., Yang, Y., Lv, M., Ye, X., Peng, G., & Fang, L. (2017b). Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving STAT2. Virology, 500, 91–95. https://doi.org/10.1016/j.virol.2016.10.014
   PubMed Web of Science ®Google Scholar
• Zumla, A., Hui, D. S., & Perlman, S. (2015). Middle East respiratory syndrome. The Lancet, 386(9997), 995–1007. https://doi.org/10.1016/S0140-6736(15)60454-8
   PubMed Web of Science ®Google Scholar